Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Mackinnon

Showing results (41-50 of 106) with videos related to

Pageof 11
Sort By:
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 13, 2018
Hepatitis E infection in stem cell and solid organ transplantpatients: A cross-sectional study: The importance of HEV RNA screening in peri-transplant periodIan Reekie, Dianne Irish, Samreen Ijaz, et al.
Immunology|November 3, 2011
Cytomegalovirus-specific CD8+ T cells targeting different peptide/HLA combinations demonstrate varying T-cell receptor diversitySandra Giest, Alasdair McWhinnie, Marie-Paule Lefranc, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 16, 2011
Leukemic priming of resting NK cells is killer Ig-like receptor independent but requires CD15-mediated CD2 ligation and natural cytotoxicity receptorsMay Sabry, Maria Tsirogianni, Ismail A Bakhsh, et al.
Blood|October 24, 2002
Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow TransplantationStephen P Robinson, Anthony H Goldstone, Stephen Mackinnon, et al.
Blood|March 8, 2003
Pharmacokinetics of alemtuzumab used for in vivo and in vitro T-cell depletion in allogeneic transplantations: relevance for early adoptive immunotherapy and infectious complicationsEmma C Morris, Peppy Rebello, Kirsty J Thomson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 1, 2006
The outcome of sibling and unrelated donor allogeneic stem cell transplantation in adult patients with acute myeloid leukemia in first remission who were initially refractory to first induction chemotherapyGordon Cook, Richard E Clark, Charles Crawley, et al.
Journal of Clinical Microbiology|March 30, 2007
Molecular investigations of an outbreak of parainfluenza virus type 3 and respiratory syncytial virus infections in a hematology unitHamid Jalal, David F Bibby, Julie Bennett, et al.
Transplantation|December 10, 2009
Phase I study of high-stringency CD8 depletion of donor leukocyte infusions after allogeneic hematopoietic stem cell transplantationGuillermo Orti, Mark Lowdell, Adele Fielding, et al.
The Journal of Experimental Medicine|January 5, 2006
The fate of human Langerhans cells in hematopoietic stem cell transplantationMatthew P Collin, Derek N J Hart, Graham H Jackson, et al.
Blood|October 25, 2003
Dose-escalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responsesKarl S Peggs, Kirsty Thomson, Daniel P Hart, et al.
Pageof 11

Showing results (41-50 of 106) with videos related to

Sort By:
Pageof 11
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 13, 2018
Hepatitis E infection in stem cell and solid organ transplantpatients: A cross-sectional study: The importance of HEV RNA screening in peri-transplant periodIan Reekie, Dianne Irish, Samreen Ijaz, et al.
Immunology|November 3, 2011
Cytomegalovirus-specific CD8+ T cells targeting different peptide/HLA combinations demonstrate varying T-cell receptor diversitySandra Giest, Alasdair McWhinnie, Marie-Paule Lefranc, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 16, 2011
Leukemic priming of resting NK cells is killer Ig-like receptor independent but requires CD15-mediated CD2 ligation and natural cytotoxicity receptorsMay Sabry, Maria Tsirogianni, Ismail A Bakhsh, et al.
Blood|October 24, 2002
Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow TransplantationStephen P Robinson, Anthony H Goldstone, Stephen Mackinnon, et al.
Blood|March 8, 2003
Pharmacokinetics of alemtuzumab used for in vivo and in vitro T-cell depletion in allogeneic transplantations: relevance for early adoptive immunotherapy and infectious complicationsEmma C Morris, Peppy Rebello, Kirsty J Thomson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 1, 2006
The outcome of sibling and unrelated donor allogeneic stem cell transplantation in adult patients with acute myeloid leukemia in first remission who were initially refractory to first induction chemotherapyGordon Cook, Richard E Clark, Charles Crawley, et al.
Journal of Clinical Microbiology|March 30, 2007
Molecular investigations of an outbreak of parainfluenza virus type 3 and respiratory syncytial virus infections in a hematology unitHamid Jalal, David F Bibby, Julie Bennett, et al.
Transplantation|December 10, 2009
Phase I study of high-stringency CD8 depletion of donor leukocyte infusions after allogeneic hematopoietic stem cell transplantationGuillermo Orti, Mark Lowdell, Adele Fielding, et al.
The Journal of Experimental Medicine|January 5, 2006
The fate of human Langerhans cells in hematopoietic stem cell transplantationMatthew P Collin, Derek N J Hart, Graham H Jackson, et al.
Blood|October 25, 2003
Dose-escalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responsesKarl S Peggs, Kirsty Thomson, Daniel P Hart, et al.
Pageof 11